Parkinson, ALS and tauopathies: new insights

The aging of the population poses a growing burden in society. This is associated with an increase in disability and diseases that have a high impact on health care, on patients and their families. Also, aging is associated with the emergence of different neurodegenerative diseases among which include Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS). Therefore, the development of advanced biological markers, new drugs and appropriate technology is the key to establishing a treatment for these diseases, which is currently an important social challenge. In our laboratory, we study the molecular basis of neurodegeneration. The research projects we develop have a multidisciplinary approach that combines basic and translational research, using cell culture techniques, murine models and postmortem samples from patients with AD, PD and ALS.